| RS2472946351 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2472950680 |
UGT1A1
|
Health Risk |
Likely pathogenic |
BILIRUBIN, SERUM LEVEL OF |
| RS2472953740 |
SLC33A1
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC33A1-related disorder, Spastic paraplegia |
| RS2472956769 |
UGT1A1
|
Health Risk |
Likely pathogenic |
Crigler-Najjar syndrome, type II |
| RS2472966631 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472967212 |
MME
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS2472968407 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472968843 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2472973234 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS2472974805 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS2472975711 |
MME
|
Health Risk |
Pathogenic |
— |
| RS2472976219 |
SETD5
|
Health Risk |
Likely pathogenic |
— |
| RS2472988765 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS2472996373 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2472996488 |
TTN
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2472996722 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2473003981 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473005339 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473006353 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473006423 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473007651 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2473007820 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473008834 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473010935 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2473017875 |
CACNA1D
|
Health Risk |
Pathogenic |
— |
| RS2473020544 |
SEC61A1
|
Health Risk |
Likely pathogenic |
Hyperuricemic nephropathy, familial juvenile type 4 |
| RS2473020552 |
SEC61A1
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2473021300 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2473027178 |
POGLUT1
|
Health Risk |
Pathogenic |
— |
| RS2473027210 |
POGLUT1
|
Health Risk |
Pathogenic |
— |
| RS2473028057 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2473036325 |
GFM1
|
Health Risk |
Likely pathogenic |
— |
| RS2473036507 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473036525 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2473037328 |
GFM1
|
Health Risk |
Likely pathogenic |
GFM1-related disorder, GFM1-related disorder |
| RS2473040267 |
POGLUT1
|
Health Risk |
Pathogenic |
— |
| RS2473044613 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473044980 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473045204 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473045218 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473045365 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473045386 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473045397 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473045441 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473045787 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473045892 |
SEC61A1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2473046112 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473057222 |
MME
|
Health Risk |
Likely pathogenic |
MME-related disorder, MME-related disorder |
| RS2473061402 |
TIMMDC1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS2473061411 |
TIMMDC1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 31 |
| RS2473064132 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473064367 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473065142 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS2473065199 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473065347 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473067623 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473067970 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473068029 |
GFM1
|
Health Risk |
Likely pathogenic |
— |
| RS2473068114 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473068223 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473068323 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473068670 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069079 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069109 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069116 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069141 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069249 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473069453 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome |
| RS2473069493 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473069504 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069629 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473069885 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473069907 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473070199 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2473070242 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072237 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072416 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072438 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473072448 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072455 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072537 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072769 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072828 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473072847 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473072963 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS2473073314 |
MME
|
Health Risk |
Pathogenic |
— |
| RS2473073532 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473073611 |
MME
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS2473073701 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473073722 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473073727 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2473073776 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473073824 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS2473073837 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473074693 |
MME
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS2473075038 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS2473081587 |
HPS3
|
Health Risk |
Likely pathogenic |
— |
| RS2473081667 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473081922 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2473082063 |
HPS3
|
Health Risk |
Pathogenic |
— |